Merck KGaA appoints Simon Sturge as new head of biosimilars unit

10:19 AM | February 20, 2014 | Deepti Ramesh

Merck KGaA says that Simon Sturge will join the company from Boehringer Ingelheim (Ingelheim, Germany) effective 1 March 2014, to head the biosimilars unit. The ...